Literature DB >> 16443691

Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development.

Eric B Harstad1, Christopher A Guite, Tami L Thomae, Christopher A Bradfield.   

Abstract

Mice harboring mutations in the Ahr locus display a patent ductus venosus and smaller livers throughout life. We tested the hypothesis that these hepatic aberrations are secondary to a developmental defect in hepatovascular blood flow by performing a detailed analysis of hepatic development in wild-type and Ahr-/- mice. This study revealed necrotic lesions in the peripheries of Ahr-/- fetal livers as early as embryonic day 15.5, with an increasing incidence up to postnatal day 1 and resolution by 2 weeks post partum. To visualize perfusion of fetal livers, we injected fluorescein isothiocyanate-labeled dextran into the cranial artery and monitored hepatic fluorescence by microscopy. The peripheries of the median and left lobes displayed decreased perfusion in regions corresponding to those regions that displayed necrosis at later developmental times. An examination of adult Ahr-/- animals revealed that smaller livers are predominantly due to decreased sizes of the left and right lobes, corresponding to regions of decreased perfusion and hepatic necrosis observed in fetal livers. Histological aberrations in the portal vein also support a model in which perfusion is compromised in the Ahr-/- liver. Taken in sum, these results indicate that the Ahr locus is required for normal perfusion of the developing liver and that disruption of the AHR signaling pathway gives rise to fetal hepatic necrosis and consequent liver deformation which persists through adult-hood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443691     DOI: 10.1124/mol.105.020107

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  26 in total

1.  Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice.

Authors:  Sun Hee Yim; Yatrik Shah; Shuhei Tomita; H Douglas Morris; Oksana Gavrilova; Gilles Lambert; Jerrold M Ward; Frank J Gonzalez
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Identification and characterization of genes susceptible to transcriptional cross-talk between the hypoxia and dioxin signaling cascades.

Authors:  KangAe Lee; Lyle D Burgoon; Laura Lamb; Edward Dere; Timothy R Zacharewski; John B Hogenesch; John J LaPres
Journal:  Chem Res Toxicol       Date:  2006-10       Impact factor: 3.739

3.  Histology Atlas of the Developing Mouse Hepatobiliary Hemolymphatic Vascular System with Emphasis on Embryonic Days 11.5-18.5 and Early Postnatal Development.

Authors:  Olivia M Swartley; Julie F Foley; David P Livingston; John M Cullen; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2016-03-08       Impact factor: 1.902

4.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

5.  Expression and role of aryl hydrocarbon receptor in Aspergillus fumigatus keratitis.

Authors:  Li Zhang; Nan Jiang; Gui-Qiu Zhao; Xu-Dong Peng; Guo-Qiang Zhu; Wei Jiang; Jing-Jing Ma
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

Review 6.  The aryl hydrocarbon receptor: a perspective on potential roles in the immune system.

Authors:  Emily A Stevens; Joshua D Mezrich; Christopher A Bradfield
Journal:  Immunology       Date:  2009-07       Impact factor: 7.397

7.  The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology.

Authors:  Manabu Nukaya; Susan Moran; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

8.  Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice.

Authors:  Iván L Csanaky; Andrew J Lickteig; Youcai Zhang; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-15       Impact factor: 4.219

9.  Ontogenic expression of hepatic Ahr mRNA is associated with histone H3K4 di-methylation during mouse liver development.

Authors:  Yue Julia Cui; Ronnie L Yeager; Xiao-Bo Zhong; Curtis D Klaassen
Journal:  Toxicol Lett       Date:  2009-05-28       Impact factor: 4.372

Review 10.  Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Authors:  Philip B Busbee; Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Nutr Rev       Date:  2013-04-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.